mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.61 |
0.03 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.39 |
0.2 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.16 |
0.6 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.1 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.2 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.12 |
0.7 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.004 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.006 |